Politics UK Notice

Health, Care & Life Sciences

Alzheimer’s Breakthrough: Insights on Lecanemab’s UK Approval

Lecanemab, a newly approved Alzheimer’s drug in the UK, represents a significant breakthrough by slowing the progression of early-stage Alzheimer’s, yet its high cost and associated risks have led to its provisional rejection for NHS use, highlighting the challenges in making advanced treatments accessible.

Read >

Curia UK’s Dementia Sprint in Northamptonshire – Enhancing Care Pathways

Last month, Curia UK hosted a dementia sprint in Northamptonshire to explore ways to enhance existing dementia care pathways. The event, hosted by Northamptonshire Carers and facilitated by former Minister for Innovation in the Department of Health and Social Care, Lord James O’Shaughnessy, and former CEO of NICE, Gillian Leng, brought together a diverse group of stakeholders to discuss and devise innovative solutions for dementia care.

Read >

Subscribe to our newsletter for your free digital copy of the journal!

Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.

Newsletter Signups
?
?

We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.

Never miss an issue by subcribing to our newsletter!

Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.

We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.

Never miss an issue by subcribing to our newsletter!

Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.

Newsletter Signups
?
?

We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.

Newsletter Signup

Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.

Newsletter Signups
?
?

We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.